Skip to main content
James Arnold

Professor James Arnold

Professor and Head of Tumour Immunology Group

Research interests

  • Cancer

Biography

James Arnold is a Professor in the Comprehensive Cancer Centre. 

The publication feed is not currently available.

Research

Tumour immunology thumbnail
Tumour Immunology Group

Tumour Immunology Group

Immunology and Immunotherapy Programme Header
Cancer Immunology & Immunotherapy

Cancer Immunology represents a broad field of research that studies host-tumour interactions as therapeutic targets in the treatment of cancer.

Project status: Ongoing

experimental-oncology
Experimental Oncology

The Experimental Oncology Programme is focused on the development of new treatments for solid tumours.

Project status: Ongoing

Spatial Biology hero
Spatial Biology Network

The Spatial Biology Network is a cross-faculty research interest group that brings together researchers from various disciplines, ranging from technology development and molecular biology, to bioinformatics and clinical translational research, to explore the complexity of spatial biology.

cancer cell banner
Cancer Biology

Cancer Biology

News

King's signs commercial contract with cellular immunotherapy startup Korecyte Bio

Korecyte Bio is leading a new approach to CAR T-cell immunotherapy to focus killing potential on cancer cells and reduce toxic side effects to help fight...

Korecyte Bio

Researchers uncover an inter-reliance of stromal cells in cancer progression

Stromal cells are the healthy cells which get drawn into cancer and can facilitate progression of the disease. In this current study, a team of researchers...

stromal cells

New open-source easy-to-use resource for the analysis of high-dimensional cytometry data launches

ImmunoCluster provides a computational framework for the non-specialist to profile complex high-dimensional data such as mass and flow cytometry.

cell floating

Engineering T-cells to selectively target cancer

Researchers from the Faculty of Life Sciences & Medicine have re-designed the genetic code of cells which can be trained to aggressively attack solid...

Researchers Drs James Arnold (Left), Paris Kosti (Middle) and John Maher (right) who developed HypoxiCAR.

Features

5 minutes with James Arnold

Dr James Arnold is a Lecturer in the Comprehensive Cancer Centre, within the School of Cancer & Pharmaceutical Sciences.

5-minutes-with-james-arnold

The publication feed is not currently available.

Research

Tumour immunology thumbnail
Tumour Immunology Group

Tumour Immunology Group

Immunology and Immunotherapy Programme Header
Cancer Immunology & Immunotherapy

Cancer Immunology represents a broad field of research that studies host-tumour interactions as therapeutic targets in the treatment of cancer.

Project status: Ongoing

experimental-oncology
Experimental Oncology

The Experimental Oncology Programme is focused on the development of new treatments for solid tumours.

Project status: Ongoing

Spatial Biology hero
Spatial Biology Network

The Spatial Biology Network is a cross-faculty research interest group that brings together researchers from various disciplines, ranging from technology development and molecular biology, to bioinformatics and clinical translational research, to explore the complexity of spatial biology.

cancer cell banner
Cancer Biology

Cancer Biology

News

King's signs commercial contract with cellular immunotherapy startup Korecyte Bio

Korecyte Bio is leading a new approach to CAR T-cell immunotherapy to focus killing potential on cancer cells and reduce toxic side effects to help fight...

Korecyte Bio

Researchers uncover an inter-reliance of stromal cells in cancer progression

Stromal cells are the healthy cells which get drawn into cancer and can facilitate progression of the disease. In this current study, a team of researchers...

stromal cells

New open-source easy-to-use resource for the analysis of high-dimensional cytometry data launches

ImmunoCluster provides a computational framework for the non-specialist to profile complex high-dimensional data such as mass and flow cytometry.

cell floating

Engineering T-cells to selectively target cancer

Researchers from the Faculty of Life Sciences & Medicine have re-designed the genetic code of cells which can be trained to aggressively attack solid...

Researchers Drs James Arnold (Left), Paris Kosti (Middle) and John Maher (right) who developed HypoxiCAR.

Features

5 minutes with James Arnold

Dr James Arnold is a Lecturer in the Comprehensive Cancer Centre, within the School of Cancer & Pharmaceutical Sciences.

5-minutes-with-james-arnold